ask="17.70"
ask_size="41000"
average_daily_volume="21779"
bid="1.00"
bid_size="500"
book_value="-0.23"
change="-0.26"
change_from_200_day_moving_average="-0.68"
change_from_50_day_moving_average="0.05"
change_from_52_week_high="-2.47"
change_From_52_week_low="1.22"
change_in_percent="-7.98%"
close="3.02"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.67"
ebitda="-49.36M"
eps_estimate_current_year="-2.25"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-2.50"
ex_dividend_date="N/A"
float_shares="10019000"
high="3.68"
high_52_weeks="5.49"
last_trade_date="1/4/2017"
last_trade_price="3.02"
last_trade_size="200"
last_trade_time="4:00pm"
low="2.80"
low_52_weeks="1.80"
market_capitalization="71.21M"
moving_average_200_day="3.70"
moving_average_50_day="2.97"
name="Oncobiologics
Inc."
notes="N/A"
one_year_target_price="11.00"
open="3.68"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-18.35%"
percent_change_from_50_day_moving_average="+1.71%"
percent_change_from_52_week_high="-44.99%"
percent_change_from_52_week_low="+67.42%"
previous_close="3.28"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="25.97"
revenue="2.98M"
shares_outstanding="23578000"
short_ratio="0.19"
stock_exchange="NGM"
symbol="ONS"
volume="34113"
weeks_range_52="1.80 - 5.49"
